190 related articles for article (PubMed ID: 27472708)
1. Association between anti-HBc positivity and hepatocellular carcinoma in HBsAg-negative subjects with chronic liver disease: A meta-analysis.
Coppola N; Onorato L; Sagnelli C; Sagnelli E; Angelillo IF
Medicine (Baltimore); 2016 Jul; 95(30):e4311. PubMed ID: 27472708
[TBL] [Abstract][Full Text] [Related]
2. Lack of correlation between serum anti-HBcore detectability and hepatocellular carcinoma in patients with HCV-related cirrhosis.
Stroffolini T; Almasio PL; Persico M; Bollani S; Benvegnù L; Di Costanzo G; Pastore G; Aghemo A; Stornaiuolo G; Mangia A; Andreone P; Stanzione M; Mazzella G; Saracco G; Del Poggio P; Bruno S;
Am J Gastroenterol; 2008 Aug; 103(8):1966-72. PubMed ID: 18637087
[TBL] [Abstract][Full Text] [Related]
3. [The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].
Kim MJ; Kwon OS; Chung NS; Lee SY; Jung HS; Park DK; Ku YS; Kim YK; Kim YS; Kim JH
Korean J Hepatol; 2008 Mar; 14(1):67-76. PubMed ID: 18367859
[TBL] [Abstract][Full Text] [Related]
4. Correlation of clinical characteristics with detection of hepatitis B virus X gene in liver tissue in HBsAg-negative, and HCV-negative hepatocellular carcinoma patients.
Higashi Y; Tada S; Miyase S; Hirota K; Imamura H; Kamio T; Suko H
Liver; 2002 Oct; 22(5):374-9. PubMed ID: 12390472
[TBL] [Abstract][Full Text] [Related]
5. Impact of occult hepatitis B virus infection and prior hepatitis B virus infection on development of hepatocellular carcinoma in patients with liver cirrhosis due to hepatitis C virus.
Adachi S; Shibuya A; Miura Y; Takeuchi A; Nakazawa T; Saigenji K
Scand J Gastroenterol; 2008; 43(7):849-56. PubMed ID: 18584524
[TBL] [Abstract][Full Text] [Related]
6. Analysis of risk factors for hepatocellular carcinoma in patients with HBs antigen- and anti-HCV antibody-negative alcoholic cirrhosis: clinical significance of prior hepatitis B virus infection.
Uetake S; Yamauchi M; Itoh S; Kawashima O; Takeda K; Ohata M
Alcohol Clin Exp Res; 2003 Aug; 27(8 Suppl):47S-51S. PubMed ID: 12960507
[TBL] [Abstract][Full Text] [Related]
7. Determination of antibody to hepatitis B core antigen by radioimmunoassay in chronic liver disease.
Mizuno M; Yamada G; Sakamoto Y; Yumoto Y; Nagashima H
Acta Med Okayama; 1980 Jun; 34(3):155-60. PubMed ID: 6251699
[TBL] [Abstract][Full Text] [Related]
8. Antibody to hepatitis B core antigen and risk for hepatitis C-related hepatocellular carcinoma: a prospective study.
Ikeda K; Marusawa H; Osaki Y; Nakamura T; Kitajima N; Yamashita Y; Kudo M; Sato T; Chiba T
Ann Intern Med; 2007 May; 146(9):649-56. PubMed ID: 17470833
[TBL] [Abstract][Full Text] [Related]
9. A prospective study on the development of hepatocellular carcinoma from liver cirrhosis with persistent hepatitis B virus infection.
Obata H; Hayashi N; Motoike Y; Hisamitsu T; Okuda H; Kobayashi S; Nishioka K
Int J Cancer; 1980 Jun; 25(6):741-7. PubMed ID: 14768703
[TBL] [Abstract][Full Text] [Related]
10. HBsAg-negative hepatitis B virus infections in hepatitis C virus-associated hepatocellular carcinoma.
Momosaki S; Nakashima Y; Kojiro M; Tabor E
J Viral Hepat; 2005 May; 12(3):325-9. PubMed ID: 15850475
[TBL] [Abstract][Full Text] [Related]
11. Clinical features of hepatocellular carcinoma seronegative for both HBsAg and anti-HCV antibody but positive for anti-HBc antibody in Japan.
Yano Y; Yamashita F; Sumie S; Ando E; Fukumori K; Kiyama M; Oyama T; Kuroki S; Kato O; Yamamoto H; Tanaka M; Sata M
Am J Gastroenterol; 2002 Jan; 97(1):156-61. PubMed ID: 11808941
[TBL] [Abstract][Full Text] [Related]
12. Anti-hepatitis B core positivity as a risk factor for hepatocellular carcinoma in alcoholic cirrhosis: a case-control study.
Kwon OS; Jung YK; Bae KS; Kim JH; Kim SG; Kim YS; Lee JI; Lee JW; Kim YS
Alcohol; 2012 Sep; 46(6):537-41. PubMed ID: 22572059
[TBL] [Abstract][Full Text] [Related]
13. The presence of hepatitis B core antibody is associated with more advanced liver disease in alcoholic patients with cirrhosis.
Zhang M; Wu R; Jiang J; Minuk GY; Niu J
Alcohol; 2013 Nov; 47(7):553-8. PubMed ID: 24041840
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and potential aetiologies of non-B non-C hepatocellular carcinoma in hepatitis B virus endemic area.
Lee SB; Kim KM; An J; Lee D; Shim JH; Lim YS; Lee HC; Chung YH; Lee YS
Liver Int; 2016 Sep; 36(9):1351-61. PubMed ID: 26913702
[TBL] [Abstract][Full Text] [Related]
15. Hepatitis C virus infection, HBsAg carrier state and hepatocellular carcinoma: relative risk and population attributable risk from a case-control study in Italy.
Stroffolini T; Chiaramonte M; Tiribelli C; Villa E; Simonetti RG; Rapicetta M; Stazi MA; Bertin T; Crocè SL; Trande P
J Hepatol; 1992 Nov; 16(3):360-3. PubMed ID: 1336785
[TBL] [Abstract][Full Text] [Related]
16. Relation between antibody to hepatitis B core antigen and survival after curative therapy for non-B non-C hepatocellular carcinoma.
Nishikawa H; Osaki Y; Arimoto A; Kita R; Kimura T
Anticancer Res; 2013 May; 33(5):2211-9. PubMed ID: 23645778
[TBL] [Abstract][Full Text] [Related]
17. Antibody to hepatitis B core antigen in patients with hepatocellular carcinoma.
Kubo Y; Okuda K; Hashimoto M; Nagasaki Y; Ebata H
Gastroenterology; 1977 Jun; 72(6):1217-20. PubMed ID: 192626
[TBL] [Abstract][Full Text] [Related]
18. Occult HBV infection in HCC and cirrhotic tissue of HBsAg-negative patients: a virological and clinical study.
Coppola N; Onorato L; Iodice V; Starace M; Minichini C; Farella N; Liorre G; Filippini P; Sagnelli E; de Stefano G
Oncotarget; 2016 Sep; 7(38):62706-62714. PubMed ID: 27486882
[TBL] [Abstract][Full Text] [Related]
19. Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.
Kumar M; Kumar R; Hissar SS; Saraswat MK; Sharma BC; Sakhuja P; Sarin SK
J Gastroenterol Hepatol; 2007 Jul; 22(7):1104-11. PubMed ID: 17559381
[TBL] [Abstract][Full Text] [Related]
20. IgM antibody to hepatitis B core antigen in Korean patients with hepatocellular carcinoma.
Sjogren MH; Lemon SM; Chung WK; Sun HS; Hoofnagle JH
Hepatology; 1984; 4(4):615-8. PubMed ID: 6204916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
